Barometer Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,827
| Closed | -$3.86M | – | 236 |
|
|
2024
Q1 | $3.86M | Buy |
9,827
+340
| +4% | +$134K | 1% | 34 |
|
|
2023
Q4 | $3.86M | Sell |
9,487
-3,342
| -26% | -$1.36M | 1.09% | 28 |
|
|
2023
Q3 | $4.46M | Buy |
12,829
+2
| +0% | +$695 | 1.41% | 25 |
|
|
2023
Q2 | $4.51M | Buy |
+12,827
| New | +$4.51M | 1.21% | 28 |
|
|
2023
Q1 | – | Sell |
-3,300
| Closed | -$953K | – | 166 |
|
|
2022
Q4 | $953K | Sell |
3,300
-11,757
| -78% | -$3.4M | 0.28% | 63 |
|
|
2022
Q3 | $4.36M | Sell |
15,057
-12,275
| -45% | -$3.55M | 1.8% | 19 |
|
|
2022
Q2 | $7.13M | Buy |
+27,332
| New | +$7.13M | 2.92% | 11 |
|
|
2020
Q3 | – | Sell |
-16,280
| Closed | -$4.73M | – | 172 |
|
|
2020
Q2 | $4.73M | Buy |
16,280
+4,580
| +39% | +$1.33M | 0.88% | 47 |
|
|
2020
Q1 | $2.78M | Sell |
11,700
-2,340
| -17% | -$557K | 0.83% | 32 |
|
|
2019
Q4 | $3.07M | Buy |
+14,040
| New | +$3.07M | 0.49% | 54 |
|
|
2019
Q2 | – | Sell |
-5,300
| Closed | -$975K | – | 171 |
|
|
2019
Q1 | $975K | Buy |
+5,300
| New | +$975K | 0.11% | 122 |
|
|
2018
Q2 | – | Sell |
-98,000
| Closed | -$16M | – | 181 |
|
|
2018
Q1 | $16M | Buy |
+98,000
| New | +$16M | 1.35% | 25 |
|
|
2015
Q1 | – | Sell |
-6,800
| Closed | -$808K | – | 170 |
|
|
2014
Q4 | $808K | Buy |
6,800
+6,157
| +958% | +$732K | 0.07% | 85 |
|
|
2014
Q3 | $72K | Buy |
+643
| New | +$72K | 0.01% | 115 |
|